[go: up one dir, main page]

KR830005856A - 소염, 해열 및 진통제 조성물 - Google Patents

소염, 해열 및 진통제 조성물 Download PDF

Info

Publication number
KR830005856A
KR830005856A KR1019810002831A KR810002831A KR830005856A KR 830005856 A KR830005856 A KR 830005856A KR 1019810002831 A KR1019810002831 A KR 1019810002831A KR 810002831 A KR810002831 A KR 810002831A KR 830005856 A KR830005856 A KR 830005856A
Authority
KR
South Korea
Prior art keywords
antipyretic
inflammatory
analgesic compositions
active ingredient
analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019810002831A
Other languages
English (en)
Inventor
스포르톨레티 지안칼로
Original Assignee
드 산티스 가스톤
이탈파르마코 쏘시에떼 퍼 아찌오니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 드 산티스 가스톤, 이탈파르마코 쏘시에떼 퍼 아찌오니 filed Critical 드 산티스 가스톤
Priority to KR1019810002831A priority Critical patent/KR830005856A/ko
Publication of KR830005856A publication Critical patent/KR830005856A/ko
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

소염, 해열 및 진통제 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 활성 성분으로써 이미다졸 살리실레이트 100내지 600mg과 불활성 담체를 함유함을 특징으로 하는 단위 용량 제형의 소염, 해열, 진통작용 및 높은 위장관 내성을 지닌 약제학적 조성물.
  2. 활성 성분으로써 이미다졸 살리실레이트를 단위 용량당 100내지 600mg함유하는 조성물을 인체에 1일 1내지 4회 투여함을 특징으로 하는 염증, 고열 및 통증 환자를 치료하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810002831A 1981-08-04 1981-08-04 소염, 해열 및 진통제 조성물 Ceased KR830005856A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019810002831A KR830005856A (ko) 1981-08-04 1981-08-04 소염, 해열 및 진통제 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019810002831A KR830005856A (ko) 1981-08-04 1981-08-04 소염, 해열 및 진통제 조성물

Publications (1)

Publication Number Publication Date
KR830005856A true KR830005856A (ko) 1983-09-14

Family

ID=54148980

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810002831A Ceased KR830005856A (ko) 1981-08-04 1981-08-04 소염, 해열 및 진통제 조성물

Country Status (1)

Country Link
KR (1) KR830005856A (ko)

Similar Documents

Publication Publication Date Title
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
KR960000219A (ko) 당뇨병 합병증 치료용 조성물
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
KR950700056A (ko) 분무-냉각된 나부메톤(Spray-chilled nabumetone)
KR920012113A (ko) 펩타이드 유도체의 사용방법
KR920000324A (ko) 필수 지방산 처리법
ATE214289T1 (de) Pernasale zusammensetzung und diese enthaltende pernasale zubereitung
KR920007629A (ko) SALMe염, 5-MTHF 및 5-FTHF 중에서 선택된 화합물 적어도 1개를 유효성분으로서 함유하여 AIDS환자의 신경학적 질환치료시 활성을 나타내는 약제학적 조성물
KR950703972A (ko) 항혈전성 치료 및 암 예방을 위한 아세틸살리실산을 함유하는 경피 투여 시스템(transdermal administration system containing acetylsalicyliic acid for antithrombotic therapy and the prevention of cancer)
KR930007441A (ko) 의약품
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
KR910005858A (ko) 지방산 요법
FR2674754B1 (fr) Composition medicamenteuse micronisee.
KR920702225A (ko) 약학 조성물
US3629412A (en) Topical anti-inflammatory agent
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
KR830005856A (ko) 소염, 해열 및 진통제 조성물
Fischer et al. Severe contact dermatitis due to nitroglycerin patches
KR890007728A (ko) 진통제 제조방법
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19810804

PG1501 Laying open of application
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19840428

Patent event code: PE09021S01D

PE0601 Decision on rejection of patent

Patent event date: 19840810

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19840428

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I